Glucocorticoids, cyclosporine, azathioprine, chlorambucil, and mycophenolate in dogs and cats: Clinical uses, pharmacology, and side effects

KR Viviano - Veterinary Clinics: Small Animal Practice, 2022 - vetsmall.theclinics.com
The body's immune system is essential for protecting it from various pathogens and other
external insults. The immune system is tightly regulated and maintained through the …

Immunomodulatory drugs and their application to the management of canine immune‐mediated disease

NT Whitley, MJ Day - Journal of Small Animal Practice, 2011 - Wiley Online Library
This review summarises the current understanding of immune response and T cell subsets
in the context of development of autoimmunity in the dog. Mode of action and rational usage …

ACVIM consensus statement on the diagnosis of immune‐mediated hemolytic anemia in dogs and cats

OA Garden, L Kidd, AM Mexas… - Journal of veterinary …, 2019 - Wiley Online Library
Immune‐mediated hemolytic anemia (IMHA) is an important cause of morbidity and mortality
in dogs. IMHA also occurs in cats, although less commonly. IMHA is considered secondary …

Prognostic factors for mortality and thromboembolism in canine immune‐mediated hemolytic anemia: a retrospective study of 72 dogs

AP Carr, DL Panciera, L Kidd - Journal of veterinary internal …, 2002 - Wiley Online Library
Medical records of 72 dogs diagnosed with immune‐mediated hemolytic anemia (IMHA)
were reviewed to find risk factors for the disease, for mortality, and for thromboembolism …

ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

JW Swann, OA Garden, CL Fellman… - Journal of veterinary …, 2019 - Wiley Online Library
Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is
associated with considerable morbidity and mortality. Treatment with various …

[图书][B] Breed predispositions to disease in dogs and cats

A Gough, A Thomas, D O'Neill - 2018 - books.google.com
Breed Predispositions to Disease in Dogs and Cats, Third Edition provides a comprehensive
exploration of current knowledge of breed predispositions based on rigorous examination of …

Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002)

TK Weinkle, SA Center, JF Randolph… - Journal of the …, 2005 - Am Vet Med Assoc
Objective—To evaluate prognostic factors, survival, and treatment protocols for immune-
mediated hemolytic anemia (IMHA) in dogs. Design—Retrospective study. Animals—151 …

Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages

PF Moore, VK Affolter, W Vernau - Veterinary pathology, 2006 - journals.sagepub.com
Histiocytic disorders of dogs include histiocytoma, localized histiocytic sarcoma (HS),
disseminated HS (malignant histocytosis), and the reactive histiocytoses: cutaneous and …

Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia

JC Scott-Moncrieff, NG Treadwell… - Journal of the …, 2001 - meridian.allenpress.com
Hemostatic parameters were prospectively measured in 20 dogs with primary immune-
mediated hemolytic anemia. Eight of 20 dogs had received prior treatment with prednisone …

Idiopathic immune‐mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs

CJ Piek, G Junius, A Dekker… - Journal of veterinary …, 2008 - Wiley Online Library
Background: Canine idiopathic immune‐mediated hemolytic anemia (IMHA) is associated
with a high mortality, especially in the 1st 2 weeks after diagnosis despite treatment …